The Exposome: Molecules to Populations

Megan M. Niedzwiecki, Douglas I. Walker, Roel Vermeulen, Marc Chadeau-Hyam, Dean P. Jones, Gary W. Miller

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    Derived from the term exposure, the exposome is an omic-scale characterization of the nongenetic drivers of health and disease. With the genome, it defines the phenome of an individual. The measurement of complex environmental factors that exert pressure on our health has not kept pace with genomics and historically has not provided a similar level of resolution. Emerging technologies make it possible to obtain detailed information on drugs, toxicants, pollutants, nutrients, and physical and psychological stressors on an omic scale. These forces can also be assessed at systems and network levels, providing a framework for advances in pharmacology and toxicology. The exposome paradigm can improve the analysis of drug interactions and detection of adverse effects of drugs and toxicants and provide data on biological responses to exposures. The comprehensive model can provide data at the individual level for precision medicine, group level for clinical trials, and population level for public health.
    Original languageEnglish
    Pages (from-to)107-127
    Number of pages21
    JournalAnnual Review of Pharmacology and Toxicology
    Volume59
    Issue number1
    DOIs
    Publication statusPublished - 6 Jan 2019

    Keywords

    • epidemiology
    • exposome
    • exposure
    • metabolomics
    • pharmacokinetics
    • systems biology

    Fingerprint

    Dive into the research topics of 'The Exposome: Molecules to Populations'. Together they form a unique fingerprint.

    Cite this